The DOI matches its Crossref record.
The Use of Dexmedetomidine Infusion for Awake Craniotomy
Abstract
Anesthesia for intracranial procedures requiring patient cooperation presents a challenge to the anesthesiologist. Drugs administered during the procedure should provide an adequate level of sedation and analgesia for bone flap removal, but must not interfere with functional testing and electrocorticography. In this case report, we describe the use of dexmedetomidine in combination with nitrous oxide and sevoflurane for bone flap removal and dexmedetomidine alone for brain mapping of the cortical speech area. Dexmedetomidine is a highly specific α2-adrenoreceptor agonist with sedative, analgesic, and anesthetic-sparing effects (1,2). It does not suppress ventilation. Small-dose infusion of this drug in healthy volunteers provided sedation that could be easily reversed with verbal stimuli (3). We anticipated that the patient treated with dexmedetomidine would be sedated and comfortable but easily arousable to tolerate a prolonged awake craniotomy. Case Report A 38-yr-old man was scheduled for resection of a left temporal brain neoplasm. The patient presented with a 14-mo history of increasing difficulty expressing himself and poorly controlled partial complex seizures. His medical history was otherwise unremarkable. The patient received no preoperative medication. In the operating room the patient was monitored with a noninvasive blood pressure cuff, a pulse oximeter, and electrocardiogram. The approximate level of sedation was measured by using a Bispectral electroencephalogram index (BIS). Anesthesia was induced with propofol 200 mg and fentanyl 100 μg IV. A laryngeal mask airway (LMA) was then placed. A right radial arterial line and Foley catheter were inserted after induction of anesthesia. The scalp nerves were blocked with 0.5% bupivacaine (4). The patient was then positioned in the right decubitus position. Anesthesia was maintained with 70% nitrous oxide, dexmedetomidine infusion (initial dose 1 μg/kg IV over 30 min followed by continuous infusion of 0.4 μg · kg−1 · hr−1 IV), and sevoflurane (0.3%–0.7%). The sevoflurane concentration was adjusted to maintain a BIS index between 50 and 60. We observed a decrease in heart rate from 62–78 bpm to 50–60 bpm and blood pressure from 95–110/55–65 mm Hg to 90–100/52–60 mm Hg after an initial dose of dexmedetomidine. The patient was breathing spontaneously throughout the procedure. Skin incision, bone flap removal, and dissection of dura were uneventful. Twenty minutes before the intended awakening, ondansetron 4 mg IV was administered, sevoflurane was discontinued and dexmedetomidine infusion was reduced to 0.2 μg · kg−1 · hr−1. The LMA was removed, and oxygen was administered via nasal cannula. Vital signs remained stable. At a dexmedetomidine infusion rate of 0.2 μg · kg−1 · hr−1 the patient was arousable, but too sedated to complete counting or sentence completion tasks (BIS 75–80). The infusion rate was reduced to 0.1 μg · kg−1 · hr−1. BIS increased to 95 within 15 min. Over 2 h were spent performing language localization. In addition to dexmedetomidine, the patient received fentanyl 100 μg. The tumor adjacent to the language areas was dissected from the normal brain while the patient was undergoing continual testing to assess language as the resection progressed. The BIS was approximately 95 while the patient was awake. An arterial blood gas sample taken during this time revealed a carbon dioxide partial pressure (Paco2) of 42 mm Hg and oxygen partial pressure (Pao2) of 156 mm Hg. The remainder of the surgical procedure was uneventful. The patient was sedated with propofol 150 mg IV and a LMA was reinserted. Dexmedetomidine infusion was discontinued and anesthesia was maintained with nitrous oxide and sevoflurane. On completion of the procedure, sevoflurane and nitrous oxide were stopped. The patient was responsive to verbal commands immediately after the LMA removal. He remembered that he was awake during the tumor resection, but could not recall any details. Discussion Anesthesia for awake craniotomy has varied from local to general with intraoperative awakening during language mapping and tumor resection (5). The combined use of droperidol and one of the lipid soluble opioids termed neuroleptanalgesia has been traditionally used to produce a state of indifference, immobility, and analgesia (6). Common intraoperative complications associated with this technique include agitation, drowsiness, pain, and seizure (7,8). Moreover, neuroleptanesthesia may lead to respiratory depression. Paco2 may reach 45–60 mm Hg (9). Several studies have endorsed the use of propofol for awake craniotomy (10,11). The use of propofol reduced the incidence of perioperative seizures and agitation, but led to a frequent incidence of respiratory depression (10). More recently, the combination of propofol and remifentanil has been successfully used for brain tumor mapping (12,13). Remifentanil’s context-sensitive half-life is short (<5 minutes) and independent of infusion durati
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Maximizing safe resection of low- and high-grade glioma
Hervey-Jumper, S. L., & Berger, M. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2110-4 · Cited by 471
Awake craniotomy to maximize glioma resection: methods and technical nuances over a 27-year period
Hervey-Jumper, S. L., Li, J., Lau, D., Molinaro, A. M., Perry, D. W., Meng, L., & Berger, M. S. (2015) · Journal of Neurosurgery · doi:10.3171/2014.10.jns141520 · Cited by 451
Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature
Schouten, J. W. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3280895d5c · Cited by 152
Metadata
- Authors
- Bekker, A. Y., Kaufman, B., Samir, H., & Doyle, W.
- Venue
- Anesthesia & Analgesia
- Published
- 2001-05
- Volume
- 92
- Issue
- 5
- Pages
- 1251-1253
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2013601340
- Cited by
- 188
- References
- 0
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Use of Dexmedetomidine Infusion for Awake Craniotomy. https://app.cochat.ai/papers/10.1097/00000539-200105000-00031
- The paper
- Bekker, A. Y., Kaufman, B., Samir, H., & Doyle, W. (2001). The Use of Dexmedetomidine Infusion for Awake Craniotomy. Anesthesia & Analgesia. https://doi.org/10.1097/00000539-200105000-00031
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.